Literature DB >> 27571790

Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival.

Taher Reza Kermanshahi1, Deepa Magge1, Haroon Choudry1, Leksmi Ramalingam1, Benjamin Zhu1, James Pingpank1, Steven Ahrendt1, Matthew Holtzman1, Herbert Zeh1, David Bartlett1, Amer Zureikat1, Reetesh K Pai1.   

Abstract

Peritoneal metastasis in colorectal carcinoma is associated with a dismal prognosis; however, features that correlate with patterns of metastatic spread are not well characterized. We analyzed the clinicopathologic and molecular features of 166 patients with colorectal carcinomas stratified by metastases to the peritoneum or liver. Mucinous and signet ring cell differentiation were more frequently observed in colorectal carcinoma with peritoneal dissemination compared to colorectal carcinoma with liver metastasis (mucinous differentiation: 62% vs 23%, P < .001; signet ring cell differentiation: 21% vs 0%, P < .0001). The significant association of mucinous differentiation with peritoneal dissemination compared with liver metastasis was identified in patients with both synchronous and metachronous development of metastasis ( P < .01). In contrast, colorectal carcinomas with liver metastasis were more frequently low-grade (90% vs 72%, P = .005) and associated with dirty necrosis (81% vs 56%, P = .001) compared with colorectal carcinomas with peritoneal dissemination. No significant differences were identified between colorectal carcinoma with peritoneal metastasis versus liver metastasis with respect to KRAS mutations, BRAF mutation, or high levels of microsatellite instability. Patients with tumors involving the peritoneum had a significantly worse overall survival in comparison to patients with liver metastasis lacking peritoneal involvement ( P = .02). When including only those patients with peritoneal metastasis, the presence of any mucinous or signet ring cell differentiation was associated with a significantly worse overall survival ( P = .006). Our findings indicate that mucinous and signet ring cell differentiation may be histologic features that are associated with an increased risk of peritoneal dissemination and poor overall survival in patients with peritoneal metastasis.

Entities:  

Keywords:  colorectal carcinoma; liver; metastases; mucinous; peritoneum; signet ring cell

Mesh:

Year:  2016        PMID: 27571790     DOI: 10.1177/1066896916664990

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  7 in total

1.  Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.

Authors:  Yiang Hui; Yihong Wang; Gahie Nam; Jacqueline Fanion; Ashlee Sturtevant; Kara A Lombardo; Murray B Resnick
Journal:  Hum Pathol       Date:  2018-01-06       Impact factor: 3.466

2.  A 15-year-old Nepali boy with metastasised colorectal cancer.

Authors:  Chloe Pinto; Zvi Howard Perry
Journal:  BMJ Case Rep       Date:  2017-06-03

3.  Synchronous metastatic colon cancer and the importance of primary tumor laterality - A National Cancer Database analysis of right- versus left-sided colon cancer.

Authors:  Beiqun Zhao; Nicole E Lopez; Samuel Eisenstein; Gabriel T Schnickel; Jason K Sicklick; Sonia L Ramamoorthy; Bryan M Clary
Journal:  Am J Surg       Date:  2019-12-12       Impact factor: 2.565

4.  Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients.

Authors:  Jianxia Li; Jianwei Zhang; Huabin Hu; Yue Cai; Jiayu Ling; Zehua Wu; Yanhong Deng
Journal:  Cancer Manag Res       Date:  2020-05-11       Impact factor: 3.989

5.  Early-Onset Signet-Ring Cell Adenocarcinoma of the Colon: A Case Report and Review of the Literature.

Authors:  Maliha Khan; Krittiya Korphaisarn; Aneeqa Saif; Wai C Foo; Scott Kopetz
Journal:  Case Rep Oncol Med       Date:  2017-02-23

6.  Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.

Authors:  Krittiya Korphaisarn; Van Morris; Jenifer S Davis; Michael J Overman; David R Fogelman; Bryan K Kee; Arvind Dasari; Kanwal P S Raghav; Imad Shureiqi; Metha Trupti; Robert A Wolff; Cathy Eng; David G Menter; Stanley Hamilton; Scott Kopetz
Journal:  Br J Cancer       Date:  2019-08-13       Impact factor: 7.640

Review 7.  Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review.

Authors:  Peilin Dai; Zaisheng Ye; Zhai Cai; Zeyu Luo; Enming Qiu; Yu Lin; Jian Cai; Hui Wang; Zhou Li; Shuai Han
Journal:  BMC Gastroenterol       Date:  2022-02-14       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.